Title:
IKZF2 DEGRADATION AGENT, PHARMACEUTICAL COMPOSITION COMPRISING SAME AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/155710
Kind Code:
A1
Abstract:
The present invention belongs to the field of medicinal chemistry, and relates to an IKZF2 degradation agent, a pharmaceutical composition comprising same and use thereof. Specifically, the IKZF2 degradation agent has a structure represented by formula (I), and can be used to prevent, ameliorate and/or treat IKAROS family zinc finger 2 (IKZF2)-related diseases or disorders.
More Like This:
Inventors:
MEI DESHENG (CN)
WU XIONG (CN)
LV SHIMING (CN)
LING XIN (CN)
XIAO CHENG (CN)
SUN GAORUI (CN)
LIU SHUAISHUAI (CN)
TAN XIAOHUA (CN)
ZHANG YARU (CN)
WU XIONG (CN)
LV SHIMING (CN)
LING XIN (CN)
XIAO CHENG (CN)
SUN GAORUI (CN)
LIU SHUAISHUAI (CN)
TAN XIAOHUA (CN)
ZHANG YARU (CN)
Application Number:
PCT/CN2023/074793
Publication Date:
August 24, 2023
Filing Date:
February 07, 2023
Export Citation:
Assignee:
SUZHOU GUOKUANG PHARMTECH CO LTD (CN)
International Classes:
A61K31/454; C07D401/14; A61K31/4545; A61P35/00; C07D401/04; C07D407/14; C07D409/14; C07D413/14; C07D417/14; C07D471/04; C07D487/04; C07D487/08; C07D495/04; C07D513/04
Domestic Patent References:
| WO2020263832A1 | 2020-12-30 | |||
| WO2021087093A1 | 2021-05-06 | |||
| WO2021173995A2 | 2021-09-02 | |||
| WO2021219078A1 | 2021-11-04 | |||
| WO2021260528A1 | 2021-12-30 | |||
| WO2022029573A1 | 2022-02-10 | |||
| WO2022081976A1 | 2022-04-21 | |||
| WO2022232391A1 | 2022-11-03 | |||
| WO2022232536A1 | 2022-11-03 | |||
| WO2023283428A1 | 2023-01-12 |
Foreign References:
| CN111051298A | 2020-04-21 | |||
| CN111629749A | 2020-09-04 | |||
| CN112261970A | 2021-01-22 | |||
| CN112334194A | 2021-02-05 | |||
| CN113271945A | 2021-08-17 | |||
| CN113329792A | 2021-08-31 | |||
| CN113372327A | 2021-09-10 | |||
| CN113490528A | 2021-10-08 | |||
| TW202140441A | 2021-11-01 |
Attorney, Agent or Firm:
LINDA LIU & PARTNERS (CN)
Download PDF: